New ICD-10-PCS Codes in

734 codes were added to the 2020 ICD-10-PCS code set, effective October 1, 2019.

Displaying codes 601-700 of 734:

  • D911BB1 Low Dose Rate (LDR) Brachytherapy of Nose using Palladium 103 (Pd-103), Unidirectional Source
  • D913BB1 Low Dose Rate (LDR) Brachytherapy of Hypopharynx using Palladium 103 (Pd-103), Unidirectional Source
  • D914BB1 Low Dose Rate (LDR) Brachytherapy of Mouth using Palladium 103 (Pd-103), Unidirectional Source
  • D915BB1 Low Dose Rate (LDR) Brachytherapy of Tongue using Palladium 103 (Pd-103), Unidirectional Source
  • D916BB1 Low Dose Rate (LDR) Brachytherapy of Salivary Glands using Palladium 103 (Pd-103), Unidirectional Source
  • D917BB1 Low Dose Rate (LDR) Brachytherapy of Sinuses using Palladium 103 (Pd-103), Unidirectional Source
  • D918BB1 Low Dose Rate (LDR) Brachytherapy of Hard Palate using Palladium 103 (Pd-103), Unidirectional Source
  • D919BB1 Low Dose Rate (LDR) Brachytherapy of Soft Palate using Palladium 103 (Pd-103), Unidirectional Source
  • D91BBB1 Low Dose Rate (LDR) Brachytherapy of Larynx using Palladium 103 (Pd-103), Unidirectional Source
  • D91DBB1 Low Dose Rate (LDR) Brachytherapy of Nasopharynx using Palladium 103 (Pd-103), Unidirectional Source
  • D91FBB1 Low Dose Rate (LDR) Brachytherapy of Oropharynx using Palladium 103 (Pd-103), Unidirectional Source
  • DB10BB1 Low Dose Rate (LDR) Brachytherapy of Trachea using Palladium 103 (Pd-103), Unidirectional Source
  • DB11BB1 Low Dose Rate (LDR) Brachytherapy of Bronchus using Palladium 103 (Pd-103), Unidirectional Source
  • DB12BB1 Low Dose Rate (LDR) Brachytherapy of Lung using Palladium 103 (Pd-103), Unidirectional Source
  • DB15BB1 Low Dose Rate (LDR) Brachytherapy of Pleura using Palladium 103 (Pd-103), Unidirectional Source
  • DB16BB1 Low Dose Rate (LDR) Brachytherapy of Mediastinum using Palladium 103 (Pd-103), Unidirectional Source
  • DB17BB1 Low Dose Rate (LDR) Brachytherapy of Chest Wall using Palladium 103 (Pd-103), Unidirectional Source
  • DB18BB1 Low Dose Rate (LDR) Brachytherapy of Diaphragm using Palladium 103 (Pd-103), Unidirectional Source
  • DD10BB1 Low Dose Rate (LDR) Brachytherapy of Esophagus using Palladium 103 (Pd-103), Unidirectional Source
  • DD11BB1 Low Dose Rate (LDR) Brachytherapy of Stomach using Palladium 103 (Pd-103), Unidirectional Source
  • DD12BB1 Low Dose Rate (LDR) Brachytherapy of Duodenum using Palladium 103 (Pd-103), Unidirectional Source
  • DD13BB1 Low Dose Rate (LDR) Brachytherapy of Jejunum using Palladium 103 (Pd-103), Unidirectional Source
  • DD14BB1 Low Dose Rate (LDR) Brachytherapy of Ileum using Palladium 103 (Pd-103), Unidirectional Source
  • DD15BB1 Low Dose Rate (LDR) Brachytherapy of Colon using Palladium 103 (Pd-103), Unidirectional Source
  • DD17BB1 Low Dose Rate (LDR) Brachytherapy of Rectum using Palladium 103 (Pd-103), Unidirectional Source
  • DF10BB1 Low Dose Rate (LDR) Brachytherapy of Liver using Palladium 103 (Pd-103), Unidirectional Source
  • DF11BB1 Low Dose Rate (LDR) Brachytherapy of Gallbladder using Palladium 103 (Pd-103), Unidirectional Source
  • DF12BB1 Low Dose Rate (LDR) Brachytherapy of Bile Ducts using Palladium 103 (Pd-103), Unidirectional Source
  • DF13BB1 Low Dose Rate (LDR) Brachytherapy of Pancreas using Palladium 103 (Pd-103), Unidirectional Source
  • DG10BB1 Low Dose Rate (LDR) Brachytherapy of Pituitary Gland using Palladium 103 (Pd-103), Unidirectional Source
  • DG11BB1 Low Dose Rate (LDR) Brachytherapy of Pineal Body using Palladium 103 (Pd-103), Unidirectional Source
  • DG12BB1 Low Dose Rate (LDR) Brachytherapy of Adrenal Glands using Palladium 103 (Pd-103), Unidirectional Source
  • DG14BB1 Low Dose Rate (LDR) Brachytherapy of Parathyroid Glands using Palladium 103 (Pd-103), Unidirectional Source
  • DG15BB1 Low Dose Rate (LDR) Brachytherapy of Thyroid using Palladium 103 (Pd-103), Unidirectional Source
  • DM10BB1 Low Dose Rate (LDR) Brachytherapy of Left Breast using Palladium 103 (Pd-103), Unidirectional Source
  • DM11BB1 Low Dose Rate (LDR) Brachytherapy of Right Breast using Palladium 103 (Pd-103), Unidirectional Source
  • DT10BB1 Low Dose Rate (LDR) Brachytherapy of Kidney using Palladium 103 (Pd-103), Unidirectional Source
  • DT11BB1 Low Dose Rate (LDR) Brachytherapy of Ureter using Palladium 103 (Pd-103), Unidirectional Source
  • DT12BB1 Low Dose Rate (LDR) Brachytherapy of Bladder using Palladium 103 (Pd-103), Unidirectional Source
  • DT13BB1 Low Dose Rate (LDR) Brachytherapy of Urethra using Palladium 103 (Pd-103), Unidirectional Source
  • DU10BB1 Low Dose Rate (LDR) Brachytherapy of Ovary using Palladium 103 (Pd-103), Unidirectional Source
  • DU11BB1 Low Dose Rate (LDR) Brachytherapy of Cervix using Palladium 103 (Pd-103), Unidirectional Source
  • DU12BB1 Low Dose Rate (LDR) Brachytherapy of Uterus using Palladium 103 (Pd-103), Unidirectional Source
  • DV10BB1 Low Dose Rate (LDR) Brachytherapy of Prostate using Palladium 103 (Pd-103), Unidirectional Source
  • DV11BB1 Low Dose Rate (LDR) Brachytherapy of Testis using Palladium 103 (Pd-103), Unidirectional Source
  • DW10BB1 Low Dose Rate (LDR) Brachytherapy of Cranial Cavity using Palladium 103 (Pd-103), Unidirectional Source
  • DW10BBZ Low Dose Rate (LDR) Brachytherapy of Cranial Cavity using Palladium 103 (Pd-103)
  • DW11BB1 Low Dose Rate (LDR) Brachytherapy of Head and Neck using Palladium 103 (Pd-103), Unidirectional Source
  • DW12BB1 Low Dose Rate (LDR) Brachytherapy of Chest using Palladium 103 (Pd-103), Unidirectional Source
  • DW13BB1 Low Dose Rate (LDR) Brachytherapy of Abdomen using Palladium 103 (Pd-103), Unidirectional Source
  • DW16BB1 Low Dose Rate (LDR) Brachytherapy of Pelvic Region using Palladium 103 (Pd-103), Unidirectional Source
  • DW1KBB1 Low Dose Rate (LDR) Brachytherapy of Upper Back using Palladium 103 (Pd-103), Unidirectional Source
  • DW1KBBZ Low Dose Rate (LDR) Brachytherapy of Upper Back using Palladium 103 (Pd-103)
  • DW1LBB1 Low Dose Rate (LDR) Brachytherapy of Lower Back using Palladium 103 (Pd-103), Unidirectional Source
  • DW1LBBZ Low Dose Rate (LDR) Brachytherapy of Lower Back using Palladium 103 (Pd-103)
  • DW1PBB1 Low Dose Rate (LDR) Brachytherapy of Gastrointestinal Tract using Palladium 103 (Pd-103), Unidirectional Source
  • DW1PBBZ Low Dose Rate (LDR) Brachytherapy of Gastrointestinal Tract using Palladium 103 (Pd-103)
  • DW1QBB1 Low Dose Rate (LDR) Brachytherapy of Respiratory Tract using Palladium 103 (Pd-103), Unidirectional Source
  • DW1QBBZ Low Dose Rate (LDR) Brachytherapy of Respiratory Tract using Palladium 103 (Pd-103)
  • DW1RBB1 Low Dose Rate (LDR) Brachytherapy of Genitourinary Tract using Palladium 103 (Pd-103), Unidirectional Source
  • DW1RBBZ Low Dose Rate (LDR) Brachytherapy of Genitourinary Tract using Palladium 103 (Pd-103)
  • DW1XBB1 Low Dose Rate (LDR) Brachytherapy of Upper Extremity using Palladium 103 (Pd-103), Unidirectional Source
  • DW1XBBZ Low Dose Rate (LDR) Brachytherapy of Upper Extremity using Palladium 103 (Pd-103)
  • DW1YBB1 Low Dose Rate (LDR) Brachytherapy of Lower Extremity using Palladium 103 (Pd-103), Unidirectional Source
  • DW1YBBZ Low Dose Rate (LDR) Brachytherapy of Lower Extremity using Palladium 103 (Pd-103)
  • X27H385 Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27H395 Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27H3B5 Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27H3C5 Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J385 Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27J395 Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J3B5 Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27J3C5 Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K385 Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27K395 Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K3B5 Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27K3C5 Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L385 Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27L395 Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L3B5 Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27L3C5 Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M385 Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27M395 Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M3B5 Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27M3C5 Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N385 Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27N395 Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N3B5 Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27N3C5 Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P385 Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27P395 Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P3B5 Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27P3C5 Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q385 Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27Q395 Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q3B5 Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27Q3C5 Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27R385 Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
  • X27R395 Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
  • X27R3B5 Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5